Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 102 participants.

Also called NCT06922994

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 102 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06922994
  • EU CT 2024-514643-28-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06922994. Randomized; quadruple masking; primary purpose treatment. Start 2025-03-31 (actual); primary completion 2026-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)
Acronym
SEARCH
Condition
Arrhythmogenic Cardiomyopathy
Intervention (Drug)
Atorvastatin 80 mg/day
Intervention (Drug)
Placebo atorvastatin
Lead sponsor
Centro Cardiologico Monzino (class: other)
Collaborator
Federico II University (class: other)
Collaborator
Università Politecnica delle Marche (class: other)
Collaborator
Ospedali dei Colli (class: other)

Record details

Record id
cardio:ct-nct06922994
Content hash
2aa3583e6228dfbff0810ead709201c9bcf2a0216e4ed92f0ebb1248803b24ae